Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-25
Closed -$5.42K – 643
2023
Q4
$5.42K Hold
25
– – ﹤0.01% 529
2023
Q3
$3.99K Hold
25
– – ﹤0.01% 554
2023
Q2
$7.21K Hold
25
– – ﹤0.01% 456
2023
Q1
$7.97K Hold
25
– – ﹤0.01% 461
2022
Q4
$7.36K Hold
25
– – ﹤0.01% 500
2022
Q3
$6K Hold
25
– – ﹤0.01% 514
2022
Q2
$5K Buy
+25
New +$5.68K ﹤0.01% 563
2020
Q4
– Sell
-54
Closed -$13K – 530
2020
Q3
$13K Hold
54
– – ﹤0.01% 363
2020
Q2
$10K Sell
54
-6
-10% -$1.15K ﹤0.01% 373
2020
Q1
$10K Buy
60
+10
+20% +$1.83K ﹤0.01% 297
2019
Q4
$9K Hold
50
– – ﹤0.01% 366
2019
Q3
$8K Hold
50
– – ﹤0.01% 384
2019
Q2
$6K Hold
50
– – ﹤0.01% 417
2019
Q1
$5K Buy
+50
New +$4.29K ﹤0.01% 415

Other funds holding PODD

Lee Financial's PODD Position: Q1 2024 in Review

Lee Financial sold out of Insulet (PODD) in Q1 2024, closing a stake of 25 shares — an estimated $5.42K sold.

Lee Financial first reported a position in PODD in Q1 2019 and held it in 14 quarters. The position peaked at $13K in Q3 2020. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Lee Financial reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 25 Insulet shares in Q1 2024, an estimated $5.42K.
  • Lee Financial first reported a position in Insulet in Q1 2019 and held it in 14 quarters.
  • Lee Financial's Insulet position peaked at $13K in Q3 2020.
  • 563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.